|
|
|
|
|
Legal status
Patent lapsed (non-payment of fees)
| (51) | INT.CL. | C07D 239/46 | (2006.01) |
| C07D 239/47 | (2006.01) | ||
| A61K 31/505 | (2006.01) |
| (11) | Number of the document | 1948620 |
| (13) | Kind of document | T |
| (96) | European patent application number | 06825836.7 |
| Date of filing the European patent application | 2006-10-12 | |
| (97) | Date of publication of the European application | 2008-07-30 |
| (45) | Date of publication and mention of the grant of the patent | 2013-03-20 |
| (46) | Date of publication of the claims translation | 2013-06-25 |
| (86) | Number | PCT/US2006/039901 |
| Date | 2006-10-12 |
| (87) | Number | WO 2007/047378 |
| Date | 2007-04-26 |
| (30) | Number | Date | Country code |
| 726290 P | 2005-10-13 | US |
| (72) |
LANGEVIN, Beverly, US
ORTON, Edward, US
SHERER, Daniel, US
|
| (73) |
Aventis Pharmaceuticals Inc.,
300 Somerset Corporate Boulevard, Bridgewater, New Jersey 08807-0800,
US
|
| (74) |
Reda ŽABOLIENĖ,
METIDA, Verslo centras "VERTAS", Gynėjų g. 16, LT-01109 Vilnius,
LT
|
| (54) | Prostaglandino D2 receptoriaus antagonisto divandenilio fosfato druska |
| DIHYDROGEN PHOSPHATE SALT OF A PROSTAGLANDIN D2 RECEPTOR ANTAGONIST |
| Payment date | Validity (years) | Amount | |
| 2013-09-25 | 8 | 640.00 LTL |
| Patent lapsed (non-payment of fees) | ||
| Invalidation date | 2014-10-12 |